Key statistics
On Friday, Cassava Sciences Inc (SAVA:NAQ) closed at 29.78, -29.43% below its 52-week high of 42.20, set on Aug 05, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 30.72 |
---|---|
High | 30.78 |
Low | 29.25 |
Bid | 29.85 |
Offer | 29.95 |
Previous close | 30.36 |
Average volume | 1.64m |
---|---|
Shares outstanding | 47.98m |
Free float | 42.21m |
P/E (TTM) | -- |
Market cap | 1.43bn USD |
EPS (TTM) | -0.4054 USD |
Data delayed at least 15 minutes, as of Sep 20 2024 21:00 BST.
More ▼
- Cassava Sciences Names Rick Barry as Chief Executive Officer
- Cassava Sciences to Present at the H.C. Wainwright Global Investment Conference
- Cassava Sciences Reports Q2 2024 Financial Results and Operational Updates
- Cassava Sciences Mourns the Death of Board Member Sanford “Sandy” Robertson
- Cassava Sciences to Hold Conference Call to Discuss Recent Developments and Provide a Company Update on Thursday, August 8, 2024 at 8:30 am ET
- Cassava Sciences Announces Expansion of Open-Label Extension Trials
- Cassava Sciences Announces Changes in Executive Leadership, Enhanced Corporate Governance and Other Initiatives
- Cassava Sciences Issues Statement on Former Science Advisor
- Cassava Sciences Reports Q1 2024 Financial Results and Clinical Updates on Phase 3 Trials of Simufilam
- Cassava Sciences Announces Over $125 Million Raised from Warrant Distribution
More ▼